Jan 16 (Reuters) - Private equity firm Carlyle Group said it would buy Johnson & Johnson's diagnostics unit for $4.15 billion.
Carlyle said the deal was expected to close in the middle of 2014.
Reuters reported in December that Carlyle was nearing an agreement to acquire Johnson & Johnson's ortho clinical diagnostics unit for about $4 billion.
- Private Equity & Hedge Funds
- Investment & Company Information
- Carlyle Group
- Johnson & Johnson